Recently Dr. Paul Pevsner of the New York University of Medicine presented four posters at a LC –MS course held at Cambridge University England. During his presentation Dr. Pevsner stated that the company’s newest innovative product (ProteoSolve LRS) was instrumental in the discovery of certain Bio-Markers in Breast and Colon cancer that could signal the disease. This patented technology allows for detergent free extraction of the lipids giving a much more homogeneous sample.
Dr. Pevsner stated the following regarding Pressure Biseciences products, “The combination of PCT and ProteoSolveLRS is particularly suited for the study of the small, often nano-quantities of samples that are usually available for proteomic studies. The combination of this method with mass spectrometry instrumentation may become a method of choice for bio-molecular identification, not just in cancer, but in neurological and coronary diseases as well.”
This is excellent news for the company in its initial growth stages as it could open the door for many new disease discoveries as well as cures. Pressure Biosciences products allow for advanced sample preparation that provides Researchers with the purest samples with which to conduct their experiments. New capabilities and potential sample preparation prospects created by the company’s technologies give way to new innovative opportunities in drug discovery, diagnostics, and biotechnology.
Pressure Bioscience is early stage company that is focused on creating and developing innovative technologies. Its Barocycler NEP3229 uses this technology to process multiple samples within minutes with the ability to customize depending on the sample type needed. They hold 13 US and 4 foreign patents covering many applications of their technology in the life sciences field.
Let us hear your thoughts: Pressure BioSciences, Inc. Message Board